News & Analysis on Clinical Trial Services & Contract Research And Development
US pharmaceutical giant Bristol-Myers Squibb (BMS) is to pay $150 million (€122 million) to settle an investigation in which regulators claimed the company gave investors an inaccurate representation of its financial performance by manipulating figures.
Shares in drug delivery company Nektar Therapeutics fell through the floor yesterday after it was suggested that regulators in Europe were not prepared to approve an inhaled insulin product for diabetes based on its technology.
Sensitech of the US has made another foray into the European market for cold chain monitoring technologies with the acquisition of Netherlands-based Temperature Data Systems.
Borculo Domo Ingredients has forged an alliance with Univar USA to act as the exclusive distributor for all of BDI's pharmaceutical lactose products in the US, the world's largest pharmaceutical market.
A report into the protein biochip industry identifies a major trend emerging in protein production, either driven by gene approaches or research purposes for therapeutic drug production. The report cites growth in the US market to eventually exceed...
Germany'sLion Bioscience has reported a slight financial improvement from a year ago, trimming losses in the first quarter. 53 per cent of the Lion's Q1 revenues, or €2.1 million were generated from Bayer projects.
Japan-based engineering firm Teikoku Piston Ring has developed a hologram identification label that brings anti-counterfeiting packaging to new levels.